|Calculated MW||82613 Da|
|Application & Usage||The peptide is used for blocking the antibody activity of active NSF. It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30 minutes at 37°C|
|Other Names||Vesicle-fusing ATPase, 220.127.116.11, N-ethylmaleimide-sensitive fusion protein, NEM-sensitive fusion protein, Suppressor of K(+) transport growth defect 2, Protein SKD2, Vesicular-fusion protein NSF, Nsf, Skd2|
|Formulation||50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 0.1% BSA and 0.02% thimerosal.|
|Reconstitution & Storage||-20 °C|
|Precautions||NSF Blocking Peptide is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Required for vesicle-mediated transport. Catalyzes the fusion of transport vesicles within the Golgi cisternae. Is also required for transport from the endoplasmic reticulum to the Golgi stack. Seems to function as a fusion protein required for the delivery of cargo proteins to all compartments of the Golgi stack GRIA2 leads to influence GRIA2 membrane cycling (By similarity).|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
If you have any additional inquiries please email technical services at email@example.com.